Series date: 
01/01/2023 - 12:30pm to 12/31/2023 - 12:30pm

DESCRIPTION
This series occurs weekly on Tuesday, 12:30 - 1:30 p.m.

This activity is a weekly conference that is clinically oriented to overview various presentations of allergic and immunologic diseases and review diagnostic measures and treatment modalities.

TARGET AUDIENCE
This course is intended for multidisciplinary (physicians and mid-level health care providers); specifically, allergy staff and paramedical staff and visitors with experience or interest in allergic diseases, at Mayo Clinic Rochester and Mayo satellites.

LEARNING OBJECTIVES
Upon conclusion of this program, participants should be able to:

•    Discuss novel, unusual, or difficult allergy and immunology cases.  On average, at least 50 cases are reviewed over the year.
•    List specific examples of improvements or modifications to patient care which resulted because of this structured learning activity.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.



Credit Statement(s):

AMA

The Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


Disclosure Summary

As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
John B. Hagan, M.D. - Takeda (i.e. Dyax/Shire) - Grant/Research Support:  Local PI on multicenter trial
James Li, M.D., Ph.D. - Stock, stock options, warrant - Abbvie
 
All relevant financial relationships have been mitigated.

No relevant financial relationship(s) with ineligible companies:
Gerald Volcheck, M.D.
Kim Baumann
 
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
John B. Hagan, M.D. : Novartis - Omalizumab (added 4/6/23)
 
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here
 

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.

COURSE DIRECTOR(S)
John B. Hagan, M.D.

QUESTIONS?
Contact Kim Baumann, Department Coordinator, at ph. 4-3783.

Support location: 
Minnesota